Proteomic identification of proteins involved in the anticancer activities of oridonin in HepG2 cells

Phytomedicine

Volumn 18, Issue 2-3, 2011, Pages 163-169

  Wang, Hui ^a   Ye, Yan ^a   Pan, Si Yuan ^b   Zhu, Guo Yuan ^a   Li, Ying Wei ^a   Fong, David W F ^a   Yu, Zhi Ling ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Apoptosis; G2 M phase arrest; Isodon rubescens; Oridonin; Proteomics

Indexed keywords

CHROMOBOX PROTEIN HOMOLOG 1 PROTEIN; GLYCINE TRANSFER RNA LIGASE; HEAT SHOCK PROTEIN 70; INORGANIC PYROPHOSPHATASE; MESSENGER RNA; ORIDONIN; POLYCYTIDYLIC ACID BINDING PROTEIN 1; PROTEIN; PROTEIN TYROSINE KINASE; PROTEOME; SERINE THREONINE KINASE RECEPTOR ASSOCIATED PROTEIN; STRESS INDUCED PHOSPHOPROTEIN 1; TELOMERASE; TRANSLATIONALLY CONTROLLED TUMOR PROTEIN; TRIFUNCTIONAL PURINE BIOSYNTHETIC PROTEIN ADENOSINE 3; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL GROWTH; CELL STRAIN HEPG2; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG MECHANISM; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; IC 50; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; UPREGULATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL PROLIFERATION; DITERPENES, KAURANE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEP G2 CELLS; HUMANS; INHIBITORY CONCENTRATION 50; ISODON; LIVER NEOPLASMS; NEOPLASM PROTEINS; PHYTOTHERAPY; PLANT EXTRACTS; POLYMERASE CHAIN REACTION; PROTEOMICS;

RABDOSIA RUBESCENS;

EID: 78651264235     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2010.06.011     Document Type: Article

References (43)

1. J.L. Bronder, and R.G. Moran A defect in the p53 response pathway induced by de novo purine synthesis inhibition J. Biol. Chem. 278 2003 48861 48871
2. B. Carpenter, C. MacKay, A. Alnabulsi, M. MacKay, C. Telfer, W.T. Melvin, and G.I. Murray The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progression Biochim. Biophys. Acta 1765 2006 85 100
3. A.C. Cato, and S. Mink BAG-1 family of cochaperones in the modulation of nuclear receptor action J. Steroid Biochem. Mol. Biol. 78 2001 379 388
4. S. Chen, J. Gao, H.D. Halicka, X. Huang, F. Traganos, and Z. Darzynkiewicz The cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineage Int. J. Oncol. 26 2005 579 588
5. J.H. Chen, S.B. Wang, D.Y. Chen, G.S. Chang, Q.F. Xin, S.J. Yuan, and Z.Y. Shen The inhibitory effect of oridonin on the growth of fifteen human cancer cell lines Zhongguo Zhong Liu Lin Chuang 4 2007 16 20
6. Y. Cheng, F. Qiu, and T. Ikejima Molecular mechanisms of oridonin-induced apoptosis and autophagy in murine fibrosarcoma L929 cells Autophagy 5 2009 430 431
7. Y. Deng, C. Lin, J. Zheng, X. Liang, J. Chen, M. Fu, P. Xiao, and M. Wu Mechanisms of arsenic trioxide induced apoptosis of human cervical cancer HeLa cells and protection by Bcl-2 Sci. China C Life Sci. 42 1999 635 643
8. Y. Gachet, S. Tournier, M. Lee, A. Lazaris-Karatzas, T. Poulton, and U.A. Bommer The growth-related, translationally controlled protein P23 has properties of a tubulin binding protein and associates transiently with microtubules during the cell cycle J. Cell Sci. 112 Pt. 8 1999 1257 1271
9. X. Gao, S.Z. Liu, Q.L. Liu, Y.Y. Liu, G.L. Zeng, and M.D. Deng Anticancer activities of oridonin in patients Ai Zheng 3 1984 201 202
10. M.E. Habel, R. Lemieux, and D. Jung Iron specific growth inhibition of Burkitt's lymphoma cells in vitro, associated with a decrease in translocated c-myc expression J. Cell. Physiol. 203 2005 277 285
11. J. Han, M. Ye, X. Qiao, W.Y. Wu, G.Q. Qu, and D.A. Guo Induction of apoptosis and G2/M cell cycle arrest by oridonin in human gastric cancer BGC-823 cells Zhongguo Yao Xue 16 2007 307 314
12. T. Hayakawa, T. Haraguchi, H. Masumoto, and Y. Hiraoka Cell cycle behavior of human HP1 subtypes: distinct molecular domains of HP1 are required for their centromeric localization during interphase and metaphase J. Cell Sci. 116 2003 3327 3338
13. T.C. Hsieh, E.K. Wijeratne, J.Y. Liang, A.L. Gunatilaka, and J.M. Wu Differential control of growth, cell cycle progression, and expression of NF-kappaB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the chinese herb Rabdosia rubescens Biochem. Biophys. Res. Commun. 337 2005 224 231
14. G.M. Hu, L.M. Liu, J.X. Zhang, X.D. Hu, H.J. Duan, H. Deng, M. He, Z.J. Luo, J.M. Liu, and J. Luo The role of XPB in cell apoptosis and viability and its relationship with p53, p21(waf1/cip1) and c-myc in hepatoma cells Dig. Liver Dis. 38 2006 755 761
15. S. Hu, S.M. Chen, X.K. Li, R. Qin, and Z.N. Mei Antitumor effects of chi-shen extract from Salvia miltiorrhiza and Paeoniae radix on human hepatocellular carcinoma cells Acta Pharmacol. Sin. 28 2007 1215 1223
16. J. Huang, L. Wu, S. Tashiro, S. Onodera, and T. Ikejima Reactive oxygen species mediate oridonin-induced HepG2 apoptosis through p53, MAPK, and mitochondrial signaling pathways J. Pharmacol. Sci. 107 2008 370 379
17. T. Ikezoe, S.S. Chen, X.J. Tong, D. Heber, H. Taguchi, and H.P. Koeffler Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells Int. J. Oncol. 23 2003 1187 1193
18. H. Jung, H.A. Seong, and H. Ha NM23-H1 tumor suppressor and its interacting partner STRAP activate p53 function J. Biol. Chem. 282 2007 35293 35307
19. S. Krajewski, M. Krajewska, B.C. Turner, C. Pratt, B. Howard, J.M. Zapata, V. Frenkel, S. Robertson, Y. Ionov, H. Yamamoto, M. Perucho, S. Takayama, and J.C. Reed Prognostic significance of apoptosis regulators in breast cancer Endocr. Relat. Cancer 6 1999 29 40
20. D. Li, L.J. Wu, S. Tashiro, S. Onodera, and T. Ikejima Oridonin inhibited the tyrosine kinase activity and induced apoptosis in human epidermoid carcinoma A431 cells Biol. Pharm. Bull. 30 2007 254 260
21. J. Liu, J.Y. liang, and T. Xie Development of Rabdosia Rubescens [Hemsl] Hara Hai Xia Yao Xue 16 2004 1 7
22. M.K. Mateyak, A.J. Obaya, and J.M. Sedivy c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points Mol. Cell. Biol. 19 1999 4672 4683
23. T. Matsui, K. Hogetsu, J. Usukura, T. Sato, T. Kumasaka, Y. Akao, and N. Tanaka Structural insight of human DEAD-box protein rck/p54 into its substrate recognition with conformational changes Genes Cells 11 2006 439 452
24. L.C. Meade-Tollin, E.M. Wijeratne, D. Cooper, M. Guild, E. Jon, A. Fritz, G.X. Zhou, L. Whitesell, J.Y. Liang, and A.A. Gunatilaka Ponicidin and oridonin are responsible for the antiangiogenic activity of Rabdosia rubescens, a constituent of the herbal supplement PC SPES J. Nat. Prod. 67 2004 2 4
25. L. Qiao, Z. Xu, T. Zhao, Z. Zhao, M. Shi, R.C. Zhao, L. Ye, and X. Zhang Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model Cell Res. 18 2008 500 507
26. R. Ran, A. Lu, L. Zhang, Y. Tang, H. Zhu, H. Xu, Y. Feng, C. Han, G. Zhou, A.C. Rigby, and F.R. Sharp Hsp70 promotes TNF-mediated apoptosis by binding IKK gamma and impairing NF-kappa B survival signaling Genes Dev. 18 2004 1466 1481
27. K.K. Ren, H.Z. Wang, L.P. Xie, D.W. Chen, X. Liu, J. Sun, Y.C. Nie, and R.Q. Zhang The effects of oridonin on cell growth, cell cycle, cell migration and differentiation in melanoma cells J. Ethnopharmacol. 103 2006 176 180
28. G.G. Sharma, K.K. Hwang, R.K. Pandita, A. Gupta, S. Dhar, J. Parenteau, M. Agarwal, H.J. Worman, R.J. Wellinger, and T.K. Pandita Human heterochromatin protein 1 isoforms HP1(Hsalpha) and HP1(Hsbeta) interfere with hTERT-telomere interactions and correlate with changes in cell growth and response to ionizing radiation Mol. Cell. Biol. 23 2003 8363 8376
29. H.D. Sun, S.X. Huang, and Q.B. Han Diterpenoids from Isodon species and their biological activities Nat. Prod. Rep. 23 2006 673 698
30. E.B. Thompson The many roles of c-Myc in apoptosis Annu. Rev. Physiol. 60 1998 575 600
31. R.L. Wang Therapeutic effects of Isodon rubescens and oridonin preparations in 31 patients with primary carcinoma of the liver Ai Zheng 3 1984 50
32. R.L. Wang, and L.X. Wang Therapeutic effects of Isodon rubescens and oridonin preparations in 95 patients with esophageal and cardioesophageal cancers Zhong Liu Fang Zhi Yan Jiu 11 1984 86 87
33. Z.N. Wang, X.D. Wo, and Y.L. Zhou Molecular mechanisms of Oridonin on tumors chemopreveention and therapy Zhongguo Yi Yao Dao Bao 5 2008 14 16
34. M. Xiang, C. Xue, L. Huicai, L. Jin, L. Hong, and H. Dacheng Large-scale identification of novel mitosis-specific phosphoproteins Biochim. Biophys. Acta 1784 2008 882 890
35. Y. Xu, Y.H. Wang, J.D. Gao, J. Ye, H.X. Zhu, N.Z. Xu, X.Y. Wang, and Z.T. Sun Suppression of c-myc expression by interference RNA in HepG2 hepatocellular carcinoma cells Zhonghua Zhong Liu Za Zhi 26 2004 458 460
36. H.W. Xue, X.L. Pan, and S.J. Yang Effect of rubescensine A on apoptosis and bcl-2, p53, fas/apo-1 and c-myc expression in GBC-SD cells Shandong Da Xue Xue Bao 43 2005 336 339
37. Y.M. Yamashita, Y. Nakaseko, I. Samejima, K. Kumada, H. Yamada, D. Michaelson, and M. Yanagida 20S cyclosome complex formation and proteolytic activity inhibited by the cAMP/PKA pathway Nature 384 1996 276 279
38. S. Yano, H. Matsuyama, H. Hirata, R. Inoue, H. Matsumoto, C. Ohmi, K. Miura, M. Shirai, N. Iizuka, and K. Naito Identification of genes linked to gefitinib treatment in prostate cancer cell lines with or without resistance to androgen: a clue to application of gefitinib to hormone-resistant prostate cancer Oncol. Rep. 15 2006 1453 1460
39. G. Zhang, and S. Wang Proteomic approach to substrates related to MAPK pathway in 293T cells Cell Biol. Int. 31 2007 1 10
40. D.R. Zhang, T.C. Ren, H.X. Lou, and J. Xing The tissue distribution in mice and pharmacokinetics in rabbits of oridonin-solid lipid nanoparticles Yao Xue Xue Bao 40 2005 573 576
41. P. Zhang, Y. Liu, N. Feng, and J. Xu Preparation and evaluation of self-microemulsifying drug delivery system of oridonin Int. J. Pharm. 355 2008 269 276
42. Y. Zhang, Y. Wu, S. Tashiro, S. Onodera, and T. Ikejima Involvement of PKC signal pathways in oridonin-induced autophagy in HeLa cells: a protective mechanism against apoptosis Biochem. Biophys. Res. Commun. 378 2009 273 278
43. G.B. Zhou, H. Kang, L. Wang, L. Gao, P. Liu, J. Xie, F.X. Zhang, X.Q. Weng, Z.X. Shen, J. Chen, L.J. Gu, M. Yan, D.E. Zhang, S.J. Chen, Z.Y. Wang, and Z. Chen Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo Blood 109 2007 3441 3450